Eco Animal Health Share Discussion Threads

[mad foetus] 10/6/2020 09:45

On a bet Tudes so probably won't be reported separately

[tudes100] 10/6/2020 09:16

buying at 220 some achievement

[aimingupward2] 10/6/2020 08:46

Well, that’s a really encouraging trading statement this morning. No wonder the share price is responding strongly.

[mad foetus] 10/6/2020 08:33

No reason why this shouldn't go back to £4, which is where it was before swine flu. Managed to buy a few at 220 first thing

[hatfullofsky] 10/6/2020 07:47

Indeed, cash burn is quite significant but margins and revenue news is great

[cerrito] 23/5/2020 10:04

Re the Friday RNS, given that the EMA has signed off on these for poultry products, I have no idea how significant it is what the EMA are doing with pork; that said good news.
Over recent weeks has been pretty quiet on the ASF front, except that it has got to India where EAH do not appear to have much activity. Perhaps reflects the world cannot focus on both Covid and ASF.
No idea if EAH working on a vaccine for ASF or even if one is feasible. However would have thought this was for a company with deeper pockets than EAH,
Went onto the corporate and commercial website to see if there was any news, but just silence.

[cerrito] 27/4/2020 16:08

The words that struck me this morning with the announcement of the new NED
was
quote
brings particular expertise in the development and commercialisation of R&D programs.
unquote
which ties in with what they said in the interims on their R&D programme.
In the current climate one thing the Board needs is someone who can take an experienced view of the many trip wires that companies like EAH face-one example being the suspension because of the virus in the US of the meet/pork processing plants of Tyson and Smithfield. I have no idea if the Chairman has that.
I am not too bothered by the fact that the new NED has no experience in the veterinary markets,

[cerrito] 11/4/2020 23:16

Trying to see what I should do with my holding here.
In the last two years there was no trading update between their interims and finals, which no doubt will come out later this year given the world wide scope of their operations.
Given all the uncertainty of both ASF and Covid, it would be good to get an update from the company.
ASF extends its reach to Poland and East Timor but could not find any recent articles on it getting anywhere near the US.
I also see that ANP have had a good run.
My current feeling given that us private investors are flying blind is that the shares are fairly valued, but other perspectives welcome.
Congrats to those who bought sub 150. I did not join you as I was distracted by other issues.

[audigger] 18/3/2020 09:13

Well I'm out at a fairly painful loss. Never imagined it would come to this. One highly speculative thought.....a while ago there was work done to investigate the anti viral properties of Aivlosin/Tylvalosin. It was shown to reduce lung injury due to viral infection - hxxps://www.researchgate.net/publication/261998379_Tylvalosin_exhibits_anti-inflammatory_property_and_attenuates_acute_lung_injury_in_different_models_possibly_through_suppression_of_NF-kB_activation

I have no idea where this work got to. Would be rather ironic if this was a potential tool for COVID-19. Unlikely I would imagine.

[cerrito] 18/3/2020 08:46

Could be and indeed I saw an article saying that there are concerns about China being able to do the planting it needs because of disruptions in the Chinese rural sector including getting fertilizer. Ok no direct link to EAH but shows the stresses against which its China operations are operating.
My first reaction was to think that somebody wanted/needed out and hence the fall.

[pugugly] 16/3/2020 11:19

No looking nice - Could it be that possibly more bad debts being discoverd in China?

[cerrito] 06/3/2020 17:03

Another article on increase in piglet prices in China and the pig/pork market there in confusion.
I see that last year the first comment on trading after the december release of interims was with the June 19 publication of the prelims,

[pugugly] 26/2/2020 13:03

Cerrito - Saw that article but was (imo) negative for EAH given the difficulty of delivery of products within the country due to lockdown restrictions - PLUS of course pssibility of increased bad debts as pig farers go but - Looks as though the market may be waking up to these problems lasting for longer than initially expected and marked down today.

[cerrito] 12/2/2020 14:09

Made me think of EAH

[pugugly] 07/2/2020 09:06

Chickens at risk "Hundreds of millions of chickens at risk of being wiped out with much of China locked down due to virus"

what likely impact on pigs which consume far more than chickens and then a knock-on impact on Eco - Also with travel and delivery lock-downs what impact on Eco sales - Looks like a possible lose - lose position - Surprised no rns from company on China position.

[hatfullofsky] 04/2/2020 16:03

I presume the fall is due to the Corona impact .....

[waldron] 30/1/2020 10:21

yep seems to be holding up well considering the news

but cannot breach the 262p resistence so might well fall back

[cerrito] 30/1/2020 10:13

Somewhat surprised that the share price has held up here given what is going on in China and let#s hope that they have collected all their extended receivables.

[waldron] 30/1/2020 09:30

30 January 2020

ECO Animal Health Group plc

(the "Group")

(AIM: EAH)

Marketing Authorisation in Indonesia

ECO Animal Health Group plc, is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the Ministry of Agriculture, Directorate General of Livestock and Animal Health of the Republic of Indonesia. The agreement is for the use of Aivlosin(R) water soluble granules in chickens laying eggs for human consumption, with a zero day drug withdrawal period for eggs. This approval has been granted under the Group's other brand name Valosin(R).

Aivlosin(R) , ECO's patented antimicrobial, is used under veterinary prescription for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Marc Loomes, CEO of ECO Animal Health Group plc, commented "Indonesia is ranked the number one market in Southeast Asia, and eighth globally, for laying bird numbers. Although the market is currently somewhat fragmented, we expect this to change in the future. It is key that the consumption of Aivlosin provides a zero day drug withdrawal period for eggs which is a significant competitive advantage for ECO. This latest approval demonstrates ECO's continued progress in rolling out this indication for commercial layers."

[waldron] 30/1/2020 09:29

Peel Hunt Buy 460.00 - Reiterates

[wjccghcc] 08/1/2020 10:37

Thanks AuDigger. I note the original patents were filed in 2001 so expiry in 2021. However, their comments on manufacturing difficulty may make generic copies less likely.

[audigger] 08/1/2020 07:40

With regards to the patent, I had some email exchange with the Directors on this back in 2016. Here are the responses I received:

"Our patents vary in length around the world and are usage ones for the molecule Tylvalosin. Many have been submitted jointly with University of Cambridge’s dept of Pathology and Virology. Their average expiry is just under 20 years. Aivlosin is VERY difficult and expensive to produce in pure form and we have not been bothered by any illegal tries to copy it"

"Patents in the animal health sector typically last up to twenty years. Numerous disease indication and use IP protection remains in place for Aivlosin® and ECO actively seeks to add to its portfolio of patents.Whilst it may be possible for generic companies to produce for the for the less regulated markets, the drug is extremely complex and thus expense to manufacture. ECO has also filed very narrow product specifications with the relevant regulatory authorities. Aivlosin® has been trademarked and strongly branded."